Nanovis aims to be the market leader in commercially available nanosurface technologies with FDA Nanotechnology Designations that enable business partners to engage the healthcare market with clinically differentiated technology. Nanosurfaces are defined by feature sizes on the nanoscale (1-100 nm) engineered to provide a biologically relevant function to gain FDA Nanotechnology Designation. The healthcare marketplace is looking for key features: antimicrobial and anti-inflammatory properties, vascular recruitment and promoting osseointegration. Nanovis offers a full spectrum approach to take advantage of the unique properties of nanosurfaces from manufacturing to implant integration. We serve our partners by developing surfaces, derisking manufacturing and receiving clearance through regulatory bodies to enable easier market adoption. Nanovis is also able to simplify agreements and logistics to apply the technology to new products. Presented by Nanovis Surface Technologies, Booth 457
